ACCESSION: MSBNK-SMB_Measured-HSA015P0088022
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 12
COMMENT: RAW_SPEC {'EL16_pos_1564': {'bp': 73299.0, 'sum': 434396.0}, 'EL14_pos_1577': {'bp': 52288.0, 'sum': 394534.0}, 'EL12_pos_1549': {'bp': 58426.0, 'sum': 442966.0}, 'EL10_pos_1556': {'bp': 53637.0, 'sum': 419904.0}, 'EL02_pos_1577': {'bp': 58817.0, 'sum': 443876.0}, 'EL11_pos_1547': {'bp': 62213.0, 'sum': 412972.0}, 'EL17_pos_1574': {'bp': 50464.0, 'sum': 368367.0}, 'EL24_pos_1561': {'bp': 68013.0, 'sum': 433015.0}, 'EL19_pos_1571': {'bp': 60727.0, 'sum': 457456.0}, 'EL15_pos_1571': {'bp': 55424.0, 'sum': 384414.0}, 'EL23_pos_1559': {'bp': 62856.0, 'sum': 447377.0}, 'EL04_pos_1579': {'bp': 43942.0, 'sum': 362464.0}}
COMMENT: RETENTION_TIME_STDEV 0.016
COMMENT: PRECURSOR_M/Z_RAW 88.076328
COMMENT: PRECURSOR_M/Z_STDEV 0.000035
COMMENT: PRECURSOR_IN_MS1 mz 88.075673; int 52.091; delta(ppm) 0.478772
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.149; C4H9NO; [M+H]+; delta(ppm) -0.149308
COMMENT: PROPOSED_MF MS-FINDER 3.437; C4H9NO; [M+H]+; delta(ppm) -0.151556
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.977; C4H9NO; [M+H]+; delta(ppm) -0.151556
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.342; C2H7N4; [M+H]+; delta(ppm) 15.093103
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H9NO; [M+H]+; delta(ppm) -0.151556
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.733; FXHOOIRPVKKKFG-UHFFFAOYSA-N; [M+H]+; CN(C)C(C)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.486; YNAVUWVOSKDBBP-UHFFFAOYSA-N; [M+H]+; C1COCCN1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.400; DNSISZSEWVHGLH-UHFFFAOYSA-N; [M+H]+; CCCC(N)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.400; GRWPTSXPZYCYOM-UHFFFAOYSA-N; [M+H]+; CN(C)CC=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.400; KGGVGTQEGGOZRN-UHFFFAOYSA-N; [M+H]+; CCCC=NO
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.815; DZQLQEYLEYWJIB-UHFFFAOYSA-N; [M+H]+; 4-Aminobutyraldehyde
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.746; YNAVUWVOSKDBBP-UHFFFAOYSA-N; [M+H]+; Morpholine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.607; DNSISZSEWVHGLH-UHFFFAOYSA-N; [M+H]+; Butyramide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.555; PMDCZENCAXMSOU-UHFFFAOYSA-N; [M+H]+; N-Ethylacetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.503; WFKAJVHLWXSISD-UHFFFAOYSA-N; [M+H]+; Isobutyramide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.503; FXHOOIRPVKKKFG-UHFFFAOYSA-N; [M+H]+; N,N-dimethylacetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.503; SYJPAKDNFZLSMV-UHFFFAOYSA-N; [M+H]+; 2-methylpropanal oxime
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.413; VYONOYYDEFODAJ-UHFFFAOYSA-N; [M+H]+; 2-(1-Aziridinyl)ethanol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.399; KGGVGTQEGGOZRN-UHFFFAOYSA-N; [M+H]+; butanal oxime
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.346; WHIVNJATOVLWBW-SNAWJCMRSA-N; [M+H]+; butanone oxime
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.346; LUQZKEZPFQRRRK-UHFFFAOYSA-N; [M+H]+; 2-methyl-2-nitrosopropane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.294; GRWPTSXPZYCYOM-UHFFFAOYSA-N; [M+H]+; 2-(dimethylamino)acetaldehyde
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.294; KVTGAKFJRLBHLU-UHFFFAOYSA-N; [M+H]+; N-isopropylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; GRWPTSXPZYCYOM-UHFFFAOYSA-N; [M+H]+; 2-(dimethylamino)acetaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; FXHOOIRPVKKKFG-UHFFFAOYSA-N; [M+H]+; N,N-dimethylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.940; DNSISZSEWVHGLH-UHFFFAOYSA-N; [M+H]+; Butyramide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.940; PMDCZENCAXMSOU-UHFFFAOYSA-N; [M+H]+; N-Ethylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.940; WFKAJVHLWXSISD-UHFFFAOYSA-N; [M+H]+; Isobutyramide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.940; KGGVGTQEGGOZRN-UHFFFAOYSA-N; [M+H]+; butanal oxime
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.940; SYJPAKDNFZLSMV-UHFFFAOYSA-N; [M+H]+; 2-methylpropanal oxime
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.940; WHIVNJATOVLWBW-SNAWJCMRSA-N; [M+H]+; butanone oxime
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.940; KVTGAKFJRLBHLU-UHFFFAOYSA-N; [M+H]+; N-isopropylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.940; LUQZKEZPFQRRRK-UHFFFAOYSA-N; [M+H]+; 2-methyl-2-nitrosopropane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.654; YNAVUWVOSKDBBP-UHFFFAOYSA-N; [M+H]+; Morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.654; VYONOYYDEFODAJ-UHFFFAOYSA-N; [M+H]+; 2-(1-Aziridinyl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; DZQLQEYLEYWJIB-UHFFFAOYSA-N; [M+H]+; 4-Aminobutyraldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.529; YNAVUWVOSKDBBP-UHFFFAOYSA-N; [M+H]+; morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.976; FXHOOIRPVKKKFG-UHFFFAOYSA-N; [M+H]+; N,N-dimethylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.284; DNSISZSEWVHGLH-UHFFFAOYSA-N; [M+H]+; butanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.085; WHIVNJATOVLWBW-UHFFFAOYSA-N; [M+H]+; N-butan-2-ylidenehydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.013; WFKAJVHLWXSISD-UHFFFAOYSA-N; [M+H]+; 2-methylpropanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.756; PMDCZENCAXMSOU-UHFFFAOYSA-N; [M+H]+; N-ethylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.628; SYJPAKDNFZLSMV-HWKANZROSA-N; [M+H]+; (NE)-N-(2-methylpropylidene)hydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.545; QJQAMHYHNCADNR-UHFFFAOYSA-N; [M+H]+; N-methylpropanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.483; JMIAPORGEDIDLT-UHFFFAOYSA-N; [M+H]+; ethyl ethanimidate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.463; KGGVGTQEGGOZRN-UHFFFAOYSA-N; [M+H]+; N-butylidenehydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.270; KVTGAKFJRLBHLU-UHFFFAOYSA-N; [M+H]+; N-propan-2-ylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.255; FNKSTXGVEUSZJJ-UHFFFAOYSA-N; [M+H]+; 3-methyl-1,3-oxazolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.214; FJLHLDBEZKTSOK-UHFFFAOYSA-N; [M+H]+; N-ethyl-N-methylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.208; VYONOYYDEFODAJ-UHFFFAOYSA-N; [M+H]+; 2-(aziridin-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.202; SUUDTPGCUKBECW-UHFFFAOYSA-N; [M+H]+; N-propylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.175; JHHZLHWJQPUNKB-UHFFFAOYSA-N; [M+H]+; pyrrolidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.133; UNCPWMREXAOVOD-UHFFFAOYSA-N; [M+H]+; 1-(methylamino)propan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.131; IJVQAJHYYRVZNE-UHFFFAOYSA-N; [M+H]+; 1-methylazetidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; JUIXJPRSYHSLHK-UHFFFAOYSA-N; [M+H]+; N-methyloxetan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.109; LUQZKEZPFQRRRK-UHFFFAOYSA-N; [M+H]+; 2-methyl-2-nitrosopropane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.081; AVPAYFOQPGPSCC-UHFFFAOYSA-N; [M+H]+; 3-methoxyazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.080; LDLAEUFQUOXALI-UHFFFAOYSA-N; [M+H]+; 3-methylazetidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.073; NQVWMPOQWBDSAI-UHFFFAOYSA-N; [M+H]+; 3-methyloxetan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.071; SUVYXKDAVYFUMG-UHFFFAOYSA-N; [M+H]+; 4-aminobutan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.071; GOPUCFKUFOFEIC-UHFFFAOYSA-N; [M+H]+; 2-methyl-1,3-oxazolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.070; QCWWEZIJUCPALZ-UHFFFAOYSA-N; [M+H]+; 1-aminobutan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.069; OLYWGXUJESDUAC-UHFFFAOYSA-N; [M+H]+; 3-aminobutan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.069; QMOLZSLXSAVSPU-UHFFFAOYSA-N; [M+H]+; N-methoxypropan-2-imine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.067; WTUJMUAZXUEIEM-UHFFFAOYSA-N; [M+H]+; propan-2-yl methanimidate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.065; QIFJASJJDSEUFV-UHFFFAOYSA-N; [M+H]+; 2-methylazetidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.065; CXBUEUVHLAPEIB-HWKANZROSA-N; [M+H]+; (E)-N-ethoxyethanimine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.050; BYJRDCYSJQJVJP-UHFFFAOYSA-N; [M+H]+; N-methoxyprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.814; OZQGLZFAWYKKLQ-UHFFFAOYSA-N; [M+H]+; oxazinane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.813; LQPOOAJESJYDLS-UHFFFAOYSA-N; [M+H]+; 1,3-oxazinane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.805; MIPHRQMEIYLZFZ-UHFFFAOYSA-N; [M+H]+; oxolan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.798; VEPSIZZAILVTSD-UHFFFAOYSA-N; [M+H]+; 1-aminobut-3-en-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.797; RKBAYXYCMQLBCZ-SCSAIBSYSA-N; [M+H]+; (2R)-2-aminobut-3-en-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.789; GNVWVYIAQBJHGV-UHFFFAOYSA-N; [M+H]+; azetidin-3-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.783; FTWWNKCHSPDIQW-UHFFFAOYSA-N; [M+H]+; azetidin-2-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.772; OBMKZINZPBARIK-UHFFFAOYSA-N; [M+H]+; (1-aminocyclopropyl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.771; JLUZCHOYSPEHES-UHFFFAOYSA-N; [M+H]+; 3-aminocyclobutan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.770; JXJORHGRCCODBV-UHFFFAOYSA-N; [M+H]+; 1-(aminomethyl)cyclopropan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.770; YHNRUSMOYCDMJS-UHFFFAOYSA-N; [M+H]+; O-(cyclopropylmethyl)hydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.764; QDEFNAHLCTUWAH-UHFFFAOYSA-N; [M+H]+; oxetan-2-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.764; WXKBWWIWJCCING-IUYQGCFVSA-N; [M+H]+; (1R,2S)-2-aminocyclobutan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.764; KTHZBRAXOLUNBN-UHFFFAOYSA-N; [M+H]+; oxetan-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.763; WHFMUIWBJFYAGJ-UHFFFAOYSA-N; [M+H]+; O-cyclobutylhydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.763; YACWILRABGNJKG-IUYQGCFVSA-N; [M+H]+; [(1R,2R)-2-aminocyclopropyl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.421; DZQLQEYLEYWJIB-UHFFFAOYSA-N; [M+H]+; 4-aminobutanal
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; VVBVTZZZFFHHSP-OWOJBTEDSA-N; [M+H]+; (E)-4-aminobut-2-en-1-ol
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C4H10N1O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 2.521
MS$FOCUSED_ION: PRECURSOR_M/Z 88.075677
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000i-9000000000-a105a0c0b32b1415b0d0
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  58.0653755 177.4619 58.066096 1.0850 42.70 -0.1119 12 f{C3H8N1}/4.30ppm,p-C1H2O1
  59.0493717 99.7243 59.050095 0.7790 28.13 -0.3000 11 f{C3H7O1}/3.90ppm,p-C1H3N1
  60.0446071 74.0225 60.045334 0.7828 15.08 0.2098 12 f{C2H6N1O1}/3.61ppm,p-C2H4
  60.0809692 105.2275 60.081696 0.9487 23.45 0.1455 11 f{C3H10N1}/3.22ppm,p-C1O1
  68.9822870 51.4570 68.983030 1.2322 14.89 -0.3727 11 ?
  69.0336062 85.7527 69.034349 0.9995 18.85 0.6294 12 f{C4H5O1}/1.67ppm,p-H5N1
  70.0288460 192.9604 70.029589 0.9282 54.70 0.6224 12 f{C3H4N1O1}/1.51ppm,p-C1H6
  70.0652675 693.3412 70.066011 0.3425 111.73 0.4476 12 f{C4H8N1}/2.02ppm,p-H2O1
  71.0128901 219.0308 71.013633 1.1829 35.08 0.1119 12 ?
  71.0492443 67.9832 71.049988 1.1541 10.84 0.1469 12 f{C4H7O1}/1.45ppm,p-H3N1
  72.0445063 632.0104 72.045249 0.4303 86.43 0.7273 12 f{C3H6N1O1}/1.61ppm,p-C1H4
  72.0809080 52.4355 72.081651 0.8601 17.82 -0.0091 11 f{C4H10N1}/1.84ppm,p-O1
  72.9981627 184.4251 72.998905 1.0411 44.72 0.4545 12 ?
  86.0236912 75.3917 86.024398 0.6626 21.60 -0.3364 11 ?
  86.0600790 328.9528 86.060786 0.6042 53.10 0.4685 12 f{C4H8N1O1}/0.45ppm,p-H2
  86.0964325 100.9108 86.097139 1.0105 27.79 -0.1364 11 ?
  86.9927232 66.5311 86.993426 1.1725 17.10 -0.4273 11 ?
  87.0441112 471.6730 87.044813 0.6434 97.88 0.4126 12 ?
  87.0553063 116.1722 87.056008 1.1832 19.86 0.1678 12 ?
  87.0916974 235.8801 87.092399 1.0334 38.04 0.1399 12 ?
  88.0215921 564.2405 88.022289 0.3976 113.51 0.4336 12 ?
  88.0393388 892.5974 88.040036 0.3635 178.63 0.6503 12 ?
  88.0757140 999.0000 88.076411 0.3179 80.30 1.0000 12 f{C4H10N1O1}/0.27ppm,p
  88.1121026 458.2358 88.112799 0.3064 108.88 0.0909 12 ?
  89.0710253 53.5145 89.071717 0.9206 16.62 -0.0500 9 ?
  89.0790498 54.4218 89.079741 1.2798 14.00 -0.1167 9 ?
  105.0032825 68.2989 105.003847 1.5428 18.52 0.2485 10 ?
PK$NUM_PEAK: 27
PK$PEAK: m/z int. rel.int.
  58.065375 177.46 177
  59.049372 99.72 99
  60.044607 74.02 74
  60.080969 105.23 105
  68.982287 51.46 51
  69.033606 85.75 85
  70.028846 192.96 192
  70.065268 693.34 693
  71.012890 219.03 219
  71.049244 67.98 67
  72.044506 632.01 632
  72.080908 52.44 52
  72.998163 184.43 184
  86.023691 75.39 75
  86.060079 328.95 328
  86.096432 100.91 100
  86.992723 66.53 66
  87.044111 471.67 471
  87.055306 116.17 116
  87.091697 235.88 235
  88.021592 564.24 564
  88.039339 892.60 892
  88.075714 999.00 999
  88.112103 458.24 458
  89.071025 53.51 53
  89.079050 54.42 54
  105.003282 68.30 68
//
